United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026)
United Therapeutics (UTHR) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 184.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 30.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.10 Mn |
| Dec 31, 2025 | 190.60 Mn |
| Sep 30, 2025 | 182.60 Mn |
| Jun 30, 2025 | 212.50 Mn |
| Mar 31, 2025 | 170.10 Mn |
| Dec 31, 2024 | 168.50 Mn |
| Sep 30, 2024 | 219.20 Mn |
| Jun 30, 2024 | 177.60 Mn |
| Mar 31, 2024 | 144.40 Mn |
| Dec 31, 2023 | 132.20 Mn |
| Sep 30, 2023 | 127.60 Mn |
| Jun 30, 2023 | 130.00 Mn |
| Mar 31, 2023 | 87.30 Mn |
| Dec 31, 2022 | 163.20 Mn |
| Sep 30, 2022 | 98.40 Mn |
| Jun 30, 2022 | 141.50 Mn |
| Mar 31, 2022 | 79.00 Mn |
| Dec 31, 2021 | 127.90 Mn |
| Sep 30, 2021 | 109.10 Mn |
| Jun 30, 2021 | 112.80 Mn |